BioSpace News Archive

Calypso Biotech, an emerging leader in the development of therapeutic antibodies for autoimmune diseases, announces today the closing of a €20M Series A financing co-led by Gilde Healthcare and Inkef Capital.

The Forum for the National Mega Innovation Program in conjunction with the press conference on the launch of Tyvyt®, hosted by Innovent Biologics, Inc., and co-sponsored by the China Association of Productivity Promotion Centers, was successfully held in Beijing

Marshalls Traditional Healthcare product helps people soothe pains naturally

Sapreme Technologies, a privately-held biotech company developing a technology platform to enable the cytosolic delivery of macromolecule therapeutics, has been awarded a 6.8 M€ grant together with a multidisciplinary consortium including 11 other academic and industrial parties.

Farlong, which develops condition-specific supplements that mix ancient remedies with modern technology, will be coming soon to StackedNutrition.com, a popular health and wellness e-commerce website.

Gossamer Bio, Inc. announced that Sheila Gujrathi, M.D., Chief Executive Officer and Co-Founder, will present at the following upcoming investor conferences:

NuChem Therapeutics Inc., a drug discovery and development contract research organization located in Montreal and specializing in medicinal and synthetic chemistry services, has completed a successful Management Buyout transaction.

Six-Month Phase 2 WILLOW Study of INS1007 in Non-Cystic Fibrosis Bronchiectasis Remains on Track to Complete Enrollment in Mid-2019

Bausch Health Companies Inc. announced that it has launched an offering of $500,000,000 aggregate principal amount of senior secured notes due 2027 and that Bausch Health Americas, Inc., the Company’s wholly owned indirect subsidiary, has launched an offering of $750,000,000 aggregate principal amount of 8.500% senior unsecured notes due 2027.

Discovery Park, a park playing a key role in the South East of England’s life sciences community, has announced the appointment of Chris Broom as Head of Business Development.